May 13, 2026 Child & Teen

The Evidence Base for DBT with Adolescents: A 2026 Update

By Brian Nuckols, MA, LPC-A

LPC-A · Center for Discovery · Gottman Trained · EFT · DBT · Depth Psychology · Pittsburgh, PA

TL;DR: Over 60 RCTs support DBT for adolescents. The 2024 BMC Psychiatry meta-analysis found a large effect size (d = 1.68) for self-harm reduction. Strong evidence covers self-harm, suicidality, emotion dysregulation, and depression. Emerging evidence extends to eating disorders, substance use, and PTSD. Gaps remain in diversity of samples and long-term follow-up data.

Why This Review Matters Now

Fifteen years ago, clinicians who used DBT with teenagers were working from extrapolation. The adult evidence was strong, the adolescent adaptations made developmental sense, and the clinical results seemed promising. But the controlled trials were few, the samples were small, and skeptics could reasonably argue that the evidence did not yet justify DBT as a standard adolescent treatment.

That argument no longer holds. The research base for DBT with adolescents has expanded dramatically since 2015, with over 60 randomized controlled trials now published across multiple countries, conditions, and clinical settings. This review synthesizes that evidence as of early 2026.

The Headline Numbers

The 2024 BMC Psychiatry meta-analysis, the most comprehensive to date, pooled data from RCTs examining DBT with adolescents across multiple outcomes. The results were striking.

Self-harm: d = 1.68 (large effect). This means the average adolescent receiving DBT showed greater reduction in self-harm than approximately 95% of adolescents in comparison conditions. This is one of the largest effect sizes in the adolescent psychotherapy literature.

Suicidal ideation: d = 0.85 (large effect). DBT significantly reduced suicidal thinking compared to both treatment as usual and active comparisons.

Depression: d = 0.62 (medium effect). DBT reduced depressive symptoms, though the effect was smaller than for self-harm, suggesting that DBT’s primary mechanism is behavioral and emotional regulation rather than direct mood improvement.

Emotion dysregulation: d = 0.91 (large effect). This is the theoretical target of DBT, and the data confirms that the treatment moves this variable substantially.

These numbers represent averages across studies with different populations, settings, and comparison conditions. Individual trials show considerable variation, but the direction of evidence is consistent.

Conditions with Strong Evidence

Self-harm and non-suicidal self-injury

This is DBT’s strongest adolescent application. The landmark Mehlum et al. (2014) trial in Norway demonstrated that DBT-A reduced self-harm significantly more than enhanced usual care over 19 weeks, with gains maintained at one-year follow-up. Subsequent replications in the UK, Australia, and the United States have confirmed these findings. McCauley et al. (2018) showed that DBT-A reduced suicide attempts, self-harm, and suicidal ideation more effectively than individual and group supportive therapy in a rigorous comparison trial.

The mechanism appears to be improved distress tolerance and emotion regulation skills. Adolescents who complete DBT have more behavioral options when distress is high, reducing the probability that self-harm functions as the default regulation strategy.

Suicidality

DBT was originally developed for chronically suicidal adults, and this focus translates to the adolescent population. Multiple trials demonstrate that DBT-A reduces both suicidal ideation and suicide attempts. The treatment hierarchy (life-threatening behavior addressed first, always) ensures that suicidality receives consistent clinical attention rather than being displaced by other concerns.

For clinicians working with suicidal adolescents, DBT offers something that few other treatments provide: a structured protocol that explicitly targets suicidality as a behavior to be analyzed, understood, and replaced with more effective responses.

Emotion dysregulation

Emotion dysregulation is the transdiagnostic mechanism that DBT targets. For adolescents, this presents as mood lability, intense emotional reactions disproportionate to triggering events, difficulty returning to baseline after emotional arousal, and impulsive behavior driven by emotional urgency. Multiple RCTs confirm that DBT reduces emotion dysregulation in adolescents regardless of the primary diagnosis.

Depression

The evidence for DBT as a depression treatment in adolescents is solid though not as distinctive as its evidence for self-harm. DBT reduces depressive symptoms, but so do CBT, interpersonal therapy, and other active treatments. Where DBT distinguishes itself is in treating depression that co-occurs with self-harm, suicidality, or emotional volatility. For these complex presentations, DBT’s integrated approach outperforms treatments that target depression alone.

Emerging Evidence

Eating disorders

DBT’s application to adolescent eating disorders focuses on the emotion regulation deficits that maintain eating pathology. For bulimia nervosa and binge eating disorder, the mechanism is direct: binge eating and purging function as emotion regulation strategies, and DBT provides replacement skills. Multiple studies show reduced binge-purge frequency and improved emotional functioning.

For anorexia nervosa, the evidence is more nuanced. Standard DBT addresses the undercontrolled, emotionally volatile presentations. RO-DBT addresses the overcontrolled, rigid presentations that characterize many restrictive eating disorders. Both approaches are represented in the emerging trial literature, though neither has the volume of evidence that self-harm applications command.

Substance use

Adolescent substance use frequently co-occurs with emotion dysregulation, and several trials have examined DBT as a treatment for co-occurring substance use and emotional/behavioral problems. The results are promising: DBT reduces substance use more effectively than treatment as usual, though the effect sizes are moderate and the studies are fewer than for self-harm.

PTSD

DBT combined with prolonged exposure (DBT-PE) has been studied in adults with PTSD and borderline personality disorder. Adolescent applications are emerging, particularly for teens with complex trauma whose PTSD symptoms are entangled with emotion dysregulation and self-harm. The rationale is that standard trauma-focused treatments assume a level of emotional stability that some traumatized adolescents do not have. DBT builds that stability first.

A growing number of studies examine DBT skills for adolescents whose ADHD includes significant emotion dysregulation, the 30% to 40% of ADHD youth who experience intense frustration, rage, and mood lability beyond what stimulant medication addresses. Early results suggest that DBT skills training improves emotional functioning in this population, though the evidence is preliminary.

How DBT Compares to Other Treatments

DBT vs. Treatment as Usual

Across conditions, DBT consistently outperforms treatment as usual (TAU) with adolescents. This is expected because TAU is often poorly defined and variable. What is notable is the size of the advantage: the effect sizes are not marginal. They represent clinically meaningful differences in self-harm frequency, emotional functioning, and crisis utilization.

DBT vs. CBT

Head-to-head comparisons with CBT are fewer than clinicians would like. The available data suggests that for anxiety disorders and uncomplicated depression, CBT and DBT perform similarly. For self-harm, suicidality, and borderline features, DBT shows an advantage. This likely reflects the treatments’ different targets: CBT restructures cognition, while DBT builds behavioral skills for emotion regulation. When the problem is distorted thinking, CBT excels. When the problem is emotional intensity that overwhelms cognitive capacity, DBT has the edge.

DBT vs. Other Active Treatments

McCauley et al. (2018) compared DBT-A to individual and group supportive therapy (IGST), an active comparison that controlled for therapeutic contact. DBT outperformed IGST on self-harm, suicide attempts, and suicidal ideation. This finding is important because it suggests that DBT’s advantages are not simply the result of more therapy contact.

Gaps in the Literature

Honest evaluation of any evidence base requires identifying what we do not yet know.

Sample diversity. Most DBT adolescent RCTs were conducted with predominantly white, female participants in Western countries. The generalizability to adolescents of color, male adolescents, non-Western cultural contexts, and gender-diverse youth remains undertested.

Long-term follow-up. Most trials follow adolescents for 6 to 12 months post-treatment. Whether DBT’s gains persist into adulthood is a critical unanswered question.

Dismantling studies. Which components of DBT are necessary? Is skills group sufficient without individual therapy? Can phone coaching be replaced with app-based support? These questions have practical implications for scalability, and the evidence to answer them is sparse.

Younger children. DBT-A was designed for adolescents ages 12 to 18. Applications for younger children exist but lack the RCT support that adolescent applications have accumulated.

Telehealth delivery. Post-pandemic, many adolescents receive DBT via telehealth. The evidence for telehealth delivery is emerging and generally positive, but definitive trials are still in progress.

Implications for Practice

The evidence supports several clinical conclusions. DBT should be a first-line consideration for adolescents presenting with self-harm, suicidality, or severe emotion dysregulation. For these presentations, the effect sizes are large and consistent across multiple independent trials. When an adolescent’s primary problem is anxiety or uncomplicated depression, CBT remains the stronger starting point. When comorbidity is high, particularly when self-harm and emotion dysregulation complicate other conditions, DBT’s transdiagnostic framework offers practical advantages. Clinicians should consider both standard DBT-A and RO-DBT, matching the treatment to the teen’s temperamental profile: undercontrolled presentations get standard DBT, overcontrolled presentations get RO-DBT.

The evidence base for DBT with adolescents is no longer emerging. It has arrived.

Frequently Asked Questions

How strong is the evidence for DBT with teenagers?

The evidence is substantial and growing. Over 60 randomized controlled trials have examined DBT with adolescents across multiple conditions. The strongest evidence supports DBT for self-harm and suicidality, where the 2024 BMC Psychiatry meta-analysis found a large effect size of d = 1.68. Strong evidence also supports DBT for emotion dysregulation and depression in adolescents. Emerging evidence covers eating disorders, substance use, PTSD, and ADHD-related emotion dysregulation. DBT consistently outperforms treatment as usual and performs comparably to or better than active comparison treatments like CBT in head-to-head trials for emotional and behavioral dysregulation.

How does DBT-A differ from adult DBT?

DBT for adolescents (DBT-A) modifies the standard adult protocol in several ways. Treatment duration is typically shorter, around 16 to 24 weeks compared to 12 months in adult DBT. Parents or caregivers participate in skills groups alongside their teens, learning the same skills so they can coach at home. The language and examples are developmentally appropriate. A fifth skills module called Walking the Middle Path addresses adolescent-specific dialectics like dependence versus independence. Individual therapy sessions may include family check-ins. Phone coaching extends to parents as well as teens.

Is DBT better than CBT for teenagers?

It depends on the presenting problem. For anxiety disorders without significant emotion dysregulation, CBT remains the first-line treatment with a stronger evidence base. For self-harm, suicidality, borderline features, and severe emotion dysregulation, DBT outperforms CBT because it directly targets the emotional instability that maintains these behaviors. For depression, both treatments show efficacy, though DBT may have an advantage when depression co-occurs with self-harm or interpersonal chaos. The clinical question is whether the teen's primary problem is distorted thinking (where CBT excels) or inability to regulate emotional intensity (where DBT excels).

What conditions does DBT treat in adolescents?

DBT has evidence for treating self-harm and non-suicidal self-injury, suicidal ideation and behavior, borderline personality disorder features, depression with emotion dysregulation, eating disorders (particularly bulimia nervosa and binge eating disorder), substance use disorders, oppositional behavior with emotional lability, and PTSD-related emotion dysregulation. Radically open DBT (RO-DBT) addresses overcontrolled presentations including restrictive eating disorders and chronic depression with social withdrawal. The common thread across all these applications is emotion dysregulation as a maintaining factor.

What are the gaps in the DBT adolescent research?

Several significant gaps remain. Most RCTs have been conducted with predominantly white, female, Western samples, limiting generalizability. Long-term follow-up data beyond 12 months is sparse for adolescent populations. Dismantling studies that identify which DBT components are necessary versus optional are few. The evidence for DBT with younger children, those under 12, is still in early stages. Research on DBT delivered via telehealth to adolescents is emerging but not yet definitive. More head-to-head comparisons with active treatments rather than treatment as usual would strengthen the evidence base.

Talk to someone who gets it →

Questions about insurance or cost? See fees and insurance info